At the end of 2019, a highly contagious infection began its ominous conquest of the world. It
was soon discovered that the disease was caused by a novel coronavirus designated as …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease
characterized by the aberrant accumulation of fibrotic tissue in the lungs parenchyma …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease, characterised by progressive scarring of the lung and associated with a high …

Rationale: Treatment options for idiopathic pulmonary fibrosis (IPF) are limited. Objectives:
To evaluate the efficacy and safety of BG00011, an anti-αvβ6 IgG1 monoclonal antibody, in …

A proportion of patients with interstitial lung diseases (ILDs) are at risk of developing a
progressive-fibrosing phenotype, which is associated with a deterioration in lung function …

We investigated the usefulness and effectiveness of tele-rehabilitation on exercise capacity
in patients with idiopathic pulmonary fibrosis (IPF). A randomized study was carried out …

Idiopathic pulmonary fibrosis (IPF) is considered the paradigmatic example of chronic
progressive fibrosing disease; IPF does not result from a primary immunopathogenic …

Exosomes are nano-sized vesicles released by almost all cell types, with a central role as
mediators of intercellular communication. In addition to physiological conditions, these …

A phase 2b trial (NCT02345070) was conducted to evaluate the efficacy and safety of two
dose levels/regimens of SAR156597 (a bispecific IgG4 antibody that binds and neutralises …

Along with increasing age and male sex, potential risk factors for IPF include cigarette
smoking, environmental exposures, microbial pathogens, and genetic factors. 1 Anyone with …